SG-328

N/A

Report date: 2025/06/11 15:02:14

Base Information

Drug NameSG-328
Drug Alias NameSG-328
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionOTC gene transference
TargetsOrnithine carbamoyltransferase
Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSana Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesSana Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A